Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00375323
Status:
COMPLETED
Last Update Posted:
2007-04-20
First Post:
2006-09-11
Brief Title:
Recombinant Factor VIIa NovoSeven on Restoring Coagulation Activation
Sponsor:
Medical University of Vienna
Organization:
Medical University of Vienna
Study Overview
Official Title:
Effects of Recombinant Factor VIIa NovoSeven on Restoring Coagulation Activation in Patients With Hemophilia A and Antibodies to Factor VIII
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to compare the effects of recombinant factor VIIa NovoSeven on restoring coagulation activation between patients with hemophilia A and antibodies to factor VIII and normal subjects controls by use of an in vivo method
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None